Archives of Clinical Infectious Diseases

Published by: Kowsar

The Debate Over Two-Dose or Three-Dose Human Papillomavirus Vaccine

Masoud Mardani 1 , *
Author Information
1 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: July 01, 2016, 11 (3); e40853
  • Published Online: July 17, 2016
  • Article Type: Editorial
  • Received: July 16, 2016
  • Accepted: July 16, 2016
  • DOI: 10.5812/archcid.40853

To Cite: Mardani M. The Debate Over Two-Dose or Three-Dose Human Papillomavirus Vaccine, Arch Clin Infect Dis. 2016 ; 11(3):e40853. doi: 10.5812/archcid.40853.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
References
  • 1. Jelastopulu E, Fafliora E, Plota A, Babalis V, Bartsokas C, Poulas K, et al. Knowledge, behaviours and attitudes regarding HPV infection and its prevention in female students in West Greece. Eur Rev Med Pharmacol Sci. 2016; 20(12): 2622-9[PubMed]
  • 2. Seyferth ER, Bratic JS, Bocchini JJ. Human papillomavirus epidemiology and vaccine recommendations: selected review of the recent literature. Curr Opin Pediatr. 2016; 28(3): 400-6[DOI][PubMed]
  • 3. Jit M, Brisson M, Laprise JF, Choi YH. Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model. BMJ. 2015; 350[DOI][PubMed]
  • 4. Brisson M, Van de Velde N, Boily MC. Economic evaluation of human papillomavirus vaccination in developed countries. Public Health Genomics. 2009; 12(5-6): 343-51[DOI][PubMed]
  • 5. Fesenfeld M, Hutubessy R, Jit M. Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review. Vaccine. 2013; 31(37): 3786-804[DOI][PubMed]
  • 6. Medscape.
  • 7. WHO.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments